Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Danilo Wegner
Observed names:
D WEGNER,
D Wegner,
D. Wegner
Institutions:
Universitätsmedizin Greifswald,
German Centre for Cardiovascular Research
Observed institutions:
University of Bonn,
Universitätsmedizin Greifswald,
Universität Greifswald,
German Centre for Cardiovascular Research
ORCID:
0000-0002-3719-1336
Observed ORCID:
0000-0002-3719-1336
OpenAlex ID:
A5020529679
Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans
2004
·
T GIESSMANN
, K MAY
, et al.
·
Clinical Pharmacology & Therapeutics
·
186
Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol
2008
·
Sierk Haenisch
, Karen May
, et al.
·
Pharmacogenetics and Genomics
·
92
Targeted adsorption of molecules in the colon with the novel adsorbent‐based Medicinal Product, DAV132: A proof of concept study in healthy subjects
2014
·
Jean de Gunzburg
, Annie Ducher
, et al.
·
The Journal of Clinical Pharmacology
·
76
The Talinolol Double-Peak Phenomenon Is Likely Caused by Presystemic Processing After Uptake from Gut Lumen
2005
·
Werner Weitschies
, Annika Bernsdorf
, et al.
·
Pharmaceutical Research
·
75
Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2
2016
·
Nikolai Siebert
, Christin Eger
, et al.
·
mAbs
·
60
PDF
Disposition and sterol-lowering effect of ezetimibe are influenced by single-dose coadministration of rifampin, an inhibitor of multidrug transport proteins
2006
·
S OSWALD
, T GIESSMANN
, et al.
·
Clinical Pharmacology & Therapeutics
·
48
Simvastatin does not influence the intestinal P‐glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms
2006
·
Annika Bernsdorf
, Thomas Giessmann
, et al.
·
British Journal of Clinical Pharmacology
·
46
Transcriptional and Post-Transcriptional Regulation of Duodenal P‑Glycoprotein and MRP2 in Healthy Human Subjects after Chronic Treatment with Rifampin and Carbamazepine
2019
·
Susanne Brueck
, Henrike Bruckmueller
, et al.
·
Molecular Pharmaceutics
·
36
Reference intervals for serum sphingosine-1-phosphate in the population-based Study of Health in Pomerania
2017
·
Eileen Moritz
, Danilo Wegner
, et al.
·
Clinica Chimica Acta
·
30
Extended‐release but not immediate‐release and subcutaneous methylnaltrexone antagonizes the loperamide‐induced delay of whole‐gut transit time in healthy subjects
2015
·
Julia Kolbow
, Christiane Modess
, et al.
·
The Journal of Clinical Pharmacology
·
19
Disposition and Antimuscarinic Effects of the Urinary Bladder Spasmolytics Propiverine: Influence of Dosage Forms and Circadian‐Time Rhythms
2008
·
Karen May
, Kristin Westphal
, et al.
·
The Journal of Clinical Pharmacology
·
18
Pharmacokinetic Drug‐Drug Interactions Between Trospium Chloride and Ranitidine Substrates of Organic Cation Transporters in Healthy Human Subjects
2019
·
Bayew Tsega Abebe
, Michael Weiss
, et al.
·
The Journal of Clinical Pharmacology
·
15
PDF
Trospium chloride is absorbed from two intestinal “absorption windows” with different permeability in healthy subjects
2016
·
Tobias Tadken
, Michael Weiss
, et al.
·
International Journal of Pharmaceutics
·
14
Oral absorption of propiverine solution and of the immediate and extended release dosage forms: influence of regioselective intestinal elimination
2008
·
Karen May
, Thomas Giessmann
, et al.
·
European Journal of Clinical Pharmacology
·
14
Intestinal and hepatic contributions to the pharmacokinetic interaction between gamithromycin and rifampicin after single‐dose and multiple‐dose administration in healthy foals
2017
·
S. Berlin
, S. Wallstabe
, et al.
·
Equine Veterinary Journal
·
10
Data on subgroup specific baseline characteristics and serum sphingosine-1-phosphate concentrations in the Study of Health in Pomerania
2017
·
Eileen Moritz
, Danilo Wegner
, et al.
·
Data in Brief
·
10
PDF
Effects of the P‐Glycoprotein Inhibitor Clarithromycin on the Pharmacokinetics of Intravenous and Oral Trospium Chloride: A 4‐Way Crossover Drug‐Drug Interaction Study in Healthy Subjects
2019
·
Bayew Tsega Abebe
, Michael Weiss
, et al.
·
The Journal of Clinical Pharmacology
·
9
Immunoadsorption in dilated cardiomyopathy: the IASO-DCM trial
2025
·
Stephan B Felix
, Michael Böhm
, et al.
·
European Heart Journal
·
2
Cellular communication network factor 1 (CCN1) associates with all-cause mortality in patients with dilated cardiomyopathy
2026
·
Roland Klingenberg
, Stefan Gross
, et al.
·
IJC Heart & Vasculature
PDF
Correlation of the novel biomarker cellular communication network factor 1 (CCN1) with miR-155 in serum of patients with dilated cardiomyopathy
2023
·
R Klingenberg
, S Gross
, et al.
·
European Heart Journal
PDF
Impact of inflammatory phenotype on prognostic discrimination for the novel biomarker cellular communication network factor 1 (CCN1) in patients with dilated cardiomyopathy
2022
·
R Klingenberg
, S Gross
, et al.
·
European Heart Journal
PDF
Cysteine-rich angiogenic inducer 61 (CCN1) independently predicts all-cause mortality in patients with dilated cardiomyopathy
2021
·
R Klingenberg
, S Gross
, et al.
·
European Heart Journal
PDF
Dose-Dependent Pharmacokinetics and Metabolisms of Prolonged-Release Ketamine Tablets in Healthy Subjects
2017
·
M. Hasan
, C. Modess
, et al.
·
Clinical Therapeutics
PDF
Pharmacokinetics and pulmonary distribution of chronic clarithromycin after simultaneous and consecutive administration of rifampicin in foals
2014
·
Sarah Berlin
, Lena Spieckermann
, et al.
·
F1000Research
Show more works
View as search
Works count:
24
Citation count:
760
H-index:
14
I10-index:
16
Year
Topic
Type